Black HE (1986). Renal toxicity of non-steroidal anti-inflammatory drugs. Toxicol. Pathol. 14: 83-90.
2.
Capecchi MR (1989). The new mouse genetics: Altering the genome by gene targeting. Trends Genet. 5: 70-76.
3.
Dinchuk JE, Car BD, Focht RJ, Johnston JJJaffee BD, Covington MB, Contel NR, Eng VM, Collins RJ, Czerniak PM, Gorry SA, and Trzaskos JM (1995). Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature378: 406-409.
4.
Hedin L., Gaddy-Kurten D., Kurten R., DeWitt DL, Smith WL, and Richards JS (1987). Prostaglandin endoperoxide synthase in rat ovarian follicles: Content, cellular distribution, and evidence for hormonal induction preceding ovulation. Endocrinology121: 722-731.
5.
Langenbach R. , Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF, Lee CA, Goulding EH, Kluckman KD, Kim HS, and Smithies O. (1995). Prostaglandin synthase I gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell83: 483-492.
6.
Morham SG, Langenbach R., Loftin CD, Tiano HF, Vouloumanos N., Jennette JC, Mahler JF, Kluckman KD, Ledford A., Lee CA, and Smithies O. (1995). Prostaglandin synthase II gene disruption causes severe renal pathology in the mouse. Cell83: 473-482.
